Abstract
For a number of years, pharmaceutical companies have departed from a tradition of strict vertical integration so as to gain access to external sources of technology and expertise for the purpose of product and technological development. It is therefore necessary to examine the strategies employed by pharmaceutical companies at both the firm and industry level. To this end, particular emphasis must be placed on strategies of collaboration and co-operation between pharmaceutical firms and external agents given that a rise in such activity follows the trend of the wider industrial community.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
